Company news

Senti Biosciences Holdings, Inc. news in 2022

Senti Biosciences Holdings, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH Annual Meeting and Investor Event

December 10, 2022

Senti Bio Reports Third Quarter Financial Results and Pipeline Updates

November 9, 2022

Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting

November 2, 2022

Senti Bio Announces New Employment Inducement Grants

October 27, 2022

Senti Bio Reports Second Quarter Financial Results and Business Updates

August 14, 2022

Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits

June 8, 2022

Decks in 2022